FDA Inspection 900868 — Fresenius Kabi Deutschland GmbH

Fresenius Kabi Deutschland GmbH — FEI 3002851530

The FDA completed an inspection of Fresenius Kabi Deutschland GmbH on Sep 26, 2014 in Friedberg (Hessen). The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 7 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 26, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Friedberg (Hessen) (Germany)

Citations

IDCFRDescription
116921 CFR 211.42(a)Buildings of Suitable Size, Construction, Location
117421 CFR 211.42(b)Product flow through building is inadequate
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
145121 CFR 211.113(b)Procedures for sterile drug products
145221 CFR 211.113(b)Validation lacking for sterile drug products
180221 CFR 211.84(b)Representative Samples
354721 CFR 211.46(b)Equipment for Environmental Control